Abstract
Mantle cell lymphoma (MCL) patients represent a difficult problem, sometimes to establish the diagnosis but mostly because of their refractoriness to standard lymphoma treatments. Which treatments to apply and to whom is not yet defined. In this study, we attempted to analyze the clinical features, to identify the major prognostic factors, and to evaluate the outcome of 121 MCL patients treated in our institution between 1979 and 1997. Clinical data, treatment modalities, and International Prognostic Index (IPI) score were evaluated. Median age was 63 years. Patients usually presented with advanced stage disease (87%), disseminated lymph nodes (57%), bone marrow involvement (79%), but with a good performance status (PS) (81%). Lymphocytosis >4000/μl and/or peripheral blood involvement was present in 36% of cases, and gastrointestinal disease in 18%. The t(11;14)(q13;q32) and/or bcl-1 rearrangement was detected in 47/57 studied cases. Median overall survival (OS) was 3.12 years and a longer survival was significantly associated with younger age (<70 years), good ps (<2), localized disease (stage i–ii), fewer than two extra-nodal sites, absence of spleen or peripheral blood involvement, normal serum ldh and β2-microglobulin levels, and hemoglobin level greater than 12 g/dl. however, the ipi failed to identify patients with longer os and in a multiparametric analysis, only older age, hemoglobin less than 12 g/dl, poor ps, and blood involvement were associated with a poorer outcome. treatment modalities had no impact on survival with 75% of patients relapsing or progressing. our data showed that the poor outcome of mcl patients is mainly related to adverse patient characteristics, a highly disseminated tumor, and some unknown parameters associated with the refractoriness to standard therapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Samaha, H., Dumontet, C., Ketterer, N. et al. Mantle cell lymphoma: a retrospective study of 121 cases. Leukemia 12, 1281–1287 (1998). https://doi.org/10.1038/sj.leu.2401121
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2401121
Keywords
This article is cited by
-
Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North American Mantle Cell Lymphoma Consortium
Journal of Hematology & Oncology (2023)
-
Clinical characteristics and outcomes of primary versus secondary gastrointestinal mantle cell lymphoma
Blood Cancer Journal (2021)
-
Palatine Tonsils Primary Presentation of Blastoid Variant of Mantle Cell Lymphoma: Case Report
Head and Neck Pathology (2021)
-
Extensive colorectal lymphomatous polyposis complicated by acute intestinal obstruction: a case report
Journal of Medical Case Reports (2017)
-
MDCT of extranodal mantle cell lymphoma: a single institute experience
Abdominal Imaging (2015)